{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T08:29:58Z","timestamp":1762504198215,"version":"3.40.5"},"reference-count":37,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","jpeds.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Journal of Pediatrics"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/j.jpeds.2017.08.071","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T03:18:06Z","timestamp":1511320686000},"page":"218-224.e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"special_numbering":"C","title":["The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia"],"prefix":"10.1016","volume":"191","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-7667-8155","authenticated-orcid":false,"given":"April","family":"Sykes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elsie","family":"Gerhardt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Tang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth E.","family":"Adderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jpeds.2017.08.071_bib0010","article-title":"Recommendations for prevention and control of influenza in children, 2016-2017","volume":"138","author":"American Academy of Pediatrics Committee on Infectious Diseases","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.15585\/mmwr.rr6505a1","article-title":"Prevention and control of seasonal influenza with vaccines","volume":"65","author":"Grohskopf","year":"2016","journal-title":"MMWR Recomm Rep"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0020","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1136\/adc.84.6.496","article-title":"Response to influenza immunisation during treatment for cancer","volume":"84","author":"Chisholm","year":"2001","journal-title":"Arch Dis Child"},{"issue":"8","key":"10.1016\/j.jpeds.2017.08.071_bib0025","article-title":"Influenza vaccination in children being treated with chemotherapy for cancer","author":"Goossen","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0030","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1016\/j.vaccine.2016.04.053","article-title":"Immunogenicity and safety of high-dose trivalent inactivated influenza vaccine compared to standard-dose vaccine in children and young adults with cancer or HIV infection","volume":"34","author":"Hakim","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0035","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4137\/CMO.S13774","article-title":"Influenza vaccination in cancer patients undergoing systemic therapy","volume":"8","author":"Shehata","year":"2014","journal-title":"Clin Med Insights Oncol"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0040","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/cam4.596","article-title":"Immunogenicity and clinical effectiveness of the trivalent inactivated influenza vaccine in immunocompromised children undergoing treatment for cancer","volume":"5","author":"Kotecha","year":"2016","journal-title":"Cancer Med"},{"year":"2013","series-title":"Global epidemiological surveillance standards for influenza","author":"World Health Association (WHO)","key":"10.1016\/j.jpeds.2017.08.071_bib0045"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0050","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiu647","article-title":"Influenza vaccine effectiveness in the United States during 2012-2013: variable protection by age and virus type","volume":"211","author":"McLean","year":"2015","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0055","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/cid\/cit736","article-title":"Influenza vaccine effectiveness in the 2011-2012 season: protection against each circulating virus and the effect of prior vaccination on estimates","volume":"58","author":"Ohmit","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0060","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1093\/cid\/cis574","article-title":"Effectiveness of seasonal influenza vaccines in the United States during a season with circulation of all three vaccine strains","volume":"55","author":"Treanor","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0065","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1002\/pbc.26110","article-title":"Serologic response and clinical efficacy of influenza vaccination in children and young adults on chemotherapy for cancer","volume":"63","author":"Choi","year":"2016","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0070","first-page":"705","article-title":"Update: influenza activity \u2014 United States, 2010-11 season, and composition of the 2011-12 influenza vaccine","volume":"60","author":"Centers for Disease Control and Prevention (CDC)","year":"2011","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0075","first-page":"414","article-title":"Update: influenza activity \u2014 United States, 2011-12 season and composition of the 2012-13 influenza vaccine","volume":"61","author":"Centers for Disease Control and Prevention (CDC)","year":"2012","journal-title":"MMWR Morb Mortal Wkly Rep"},{"year":"2013","series-title":"2012-2013 influenza season surveillance summary","author":"Centers for Disease Control and Prevention (CDC)","key":"10.1016\/j.jpeds.2017.08.071_bib0080"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0085","doi-asserted-by":"crossref","first-page":"34","DOI":"10.4161\/hv.8.1.18214","article-title":"Correlates of vaccine protection from influenza and its complications","volume":"8","author":"McCullers","year":"2012","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0090","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S0022-3476(89)80325-7","article-title":"Influenza in children with cancer","volume":"115","author":"Kempe","year":"1989","journal-title":"J Pediatr"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0095","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2288-10-18","article-title":"Relationship between haemagglutination-inhibiting antibody titres and clinical protection against influenza: development and application of a Bayesian random-effects model","volume":"10","author":"Coudeville","year":"2010","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0100","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1093\/infdis\/jit372","article-title":"Estimation of the association between antibody titers and protection against confirmed influenza virus infection in children","volume":"208","author":"Ng","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0105","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1097\/INF.0b013e3182367662","article-title":"Hemagglutination inhibition antibody titers as a correlate of protection for inactivated influenza vaccines in children","volume":"30","author":"Black","year":"2011","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0110","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1586\/erv.12.69","article-title":"Pediatric influenza vaccination: understanding the T-cell response","volume":"11","author":"Bodewes","year":"2012","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0115","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ni.3056","article-title":"Antiviral B cell and T cell immunity in the lungs","volume":"16","author":"Chiu","year":"2015","journal-title":"Nat Immunol"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0120","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1002\/pbc.21327","article-title":"Longitudinal assessment of immunological status and rate of immune recovery following treatment in children with ALL","volume":"50","author":"Kosmidis","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MPH.0000000000000697","article-title":"Immune dysfunction after completion of childhood leukemia therapy","volume":"39","author":"Perkins","year":"2017","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0130","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/j.vaccine.2011.11.105","article-title":"Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults","volume":"30","author":"Hakim","year":"2012","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0135","doi-asserted-by":"crossref","first-page":"e177","DOI":"10.1097\/MPH.0b013e3181d869f3","article-title":"The efficacy of influenza vaccination in a pediatric oncology population","volume":"32","author":"Reilly","year":"2010","journal-title":"J Pediatr Hematol Oncol"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0140","first-page":"1","article-title":"Factors affecting immune responses to the influenza vaccine","author":"Castrucci","year":"2017","journal-title":"Hum Vaccin Immunother"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0145","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/irv.12058","article-title":"A prospective study of chemotherapy immunologic effects and predictors of humoral influenza vaccine responses in a pediatric oncology cohort","volume":"7","author":"Kersun","year":"2013","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0150","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1002\/pbc.24893","article-title":"Immunogenicity of a 2009 pandemic influenza virus A H1N1 vaccine, administered simultaneously with the seasonal influenza vaccine, in children receiving chemotherapy","volume":"61","author":"Ottoffy","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0155","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1097\/INF.0b013e318267f7d9","article-title":"Clinical and demographic characteristics of seasonal influenza in pediatric patients with cancer","volume":"31","author":"Carr","year":"2012","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0160","doi-asserted-by":"crossref","first-page":"e540","DOI":"10.1542\/peds.2014-0943","article-title":"Quality improvement initiative to increase influenza vaccination in pediatric cancer patients","volume":"135","author":"Freedman","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0165","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1542\/peds.2014-1105","article-title":"Parental Tdap boosters and infant pertussis: a case-control study","volume":"134","author":"Quinn","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0170","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1016\/j.vaccine.2015.10.119","article-title":"Effects of repeated annual inactivated influenza vaccination among healthcare personnel on serum hemagglutinin inhibition antibody response to A\/Perth\/16\/2009 (H3N2)-like virus during 2010-11","volume":"34","author":"Thompson","year":"2016","journal-title":"Vaccine"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0175","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1093\/cid\/ciw176","article-title":"A perfect storm: impact of genomic variation and serial vaccination on low influenza vaccine efectiveness during the 2014-2015 season","volume":"63","author":"Skowronski","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0180","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1086\/518985","article-title":"Safety and tolerability of oseltamivir prophylaxis in hematopoietic stem cell transplant recipients: a retrospective case-control study","volume":"15","author":"Vu","year":"2007","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jpeds.2017.08.071_bib0185","doi-asserted-by":"crossref","first-page":"e113633","DOI":"10.1371\/journal.pone.0113633","article-title":"Use of neuraminidase inhibitors for rapid containment of influenza: a systematic review and meta-analysis of individual and household transmission studies","volume":"9","author":"Okoli","year":"2014","journal-title":"PLoS ONE"},{"issue":"1","key":"10.1016\/j.jpeds.2017.08.071_bib0190","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002744.pub3","article-title":"Neuraminidase inhibitors for preventing and treating influenza in children","author":"Wang","year":"2012","journal-title":"Cochrane Database Syst Rev"}],"container-title":["The Journal of Pediatrics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617311526?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022347617311526?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2021,4,4]],"date-time":"2021-04-04T21:08:03Z","timestamp":1617570483000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022347617311526"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,12]]},"references-count":37,"alternative-id":["S0022347617311526"],"URL":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.08.071","relation":{},"ISSN":["0022-3476"],"issn-type":[{"type":"print","value":"0022-3476"}],"subject":[],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The Effectiveness of Trivalent Inactivated Influenza Vaccine in Children with Acute Leukemia","name":"articletitle","label":"Article Title"},{"value":"The Journal of Pediatrics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jpeds.2017.08.071","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}